TWD 20.0
(6.1%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.59 Billion TWD | 16.0% |
2022 | 2.23 Billion TWD | 9.49% |
2021 | 2.04 Billion TWD | 17.81% |
2020 | 1.73 Billion TWD | -7.15% |
2019 | 1.86 Billion TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 2.19 Billion TWD | 0.0% |
2024 Q1 | 2.19 Billion TWD | -15.56% |
2023 Q1 | 1.89 Billion TWD | -15.31% |
2023 FY | 2.59 Billion TWD | 16.0% |
2023 Q4 | 2.59 Billion TWD | 0.0% |
2023 Q3 | 2.59 Billion TWD | 36.97% |
2023 Q2 | 1.89 Billion TWD | 0.0% |
2022 Q4 | 2.23 Billion TWD | 0.0% |
2022 FY | 2.23 Billion TWD | 9.49% |
2021 FY | 2.04 Billion TWD | 17.81% |
2020 FY | 1.73 Billion TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Lytone Enterprise, Inc. | 219.12 Million TWD | -1085.448% |
Vetnostrum Animal Health Co., Ltd. | 317.58 Million TWD | -717.937% |